Ben Stanger, MD
Gastroenterology · Philadelphia, PANPI 1730179813
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,731 of the $16,731 with a category attached, or 100.0%. Boehringer Ingelheim RCV GmbH & Co KG accounts for 62.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $10,451 and has fallen 76.7% since, to $2,430 in 2025.
Across 4 payments — averaging $4182.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim RCV GmbH & Co KG$10K
- E.r. Squibb & Sons, L.L.C.$4K
- Incyte Corporation$2K
Across 7 payments — averaging $114,053 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$743K
- Merck$35K
- Incyte Corporation$20K
What the payments were for
- Consulting fees$16,731100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim RCV GmbH & Co KG | 2 | $10,451 |
| E.r. Squibb & Sons, L.L.C. | 1 | $3,850 |
| Incyte Corporation | 1 | $2,430 |
How this compares
$16,731 in reported general payments places this provider in the 85th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Philadelphia
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
- Gregory GinsbergPhiladelphia$234K
- Neilanjan NandiPhiladelphia$209K
- David LichtensteinPhiladelphia$192K
- Alexander SchlachtermanPhiladelphia$188K
- Kuchikala ReddyPhiladelphia$182K
- James LewisPhiladelphia$175K
- Beth GardnerPhiladelphia$122K
- Gary FalkPhiladelphia$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.